Sorrento Therapeutics Banner Image

Sorrento Therapeutics

  • Ticker SRNE
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Sorrento Therapeutics Logo Image
  • 51-200 Employees
  • Based in San Diego, California
Sorrento Therapeutics is an antibody-centric, clinical stage biopharmaceutical company developing new treatments for cancer, inflammation and autoimmune diseases. Sorrento's lead products are multiple late-stage biosimilar and biobetter antibodies, as well as clinical CAR-T therapies targeting solid tumors.
4.8 / 5.0 (158)

Sorrento Therapeutics reports have an aggregate usefulness score of 4.8 based on 158 reviews.

Sorrento Therapeutics

Most Recent Annual Report

Sorrento Therapeutics
MOST RECENT 2022 Annual Report and Form 10K

Sorrento Therapeutics does not currently have any hardcopy reports on AnnualReports.com. Click the button below to request a report when hardcopies become available.

Request Information

Older/Archived Annual Reports

Sorrento Therapeutics Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!